Department of Internal Medicine, Gulhane Military Medical Academy, 06018 Etlik, Ankara, Turkey.
Environ Toxicol Pharmacol. 2011 Jan;31(1):165-70. doi: 10.1016/j.etap.2010.10.003. Epub 2010 Oct 23.
Neopterin is synthesized in macrophage/Kupffer cells by interferon-gamma and other cytokines. This study aimed to evaluate the utility of using neopterin as a biomarker of acetaminophen (APAP)-induced liver injury. Wistar rats, randomly divided into two groups (APAP and normal), received APAP (1.0 g/kg) and distilled water, respectively, by gastric tube. The APAP group had a higher degree of liver necrosis than the control group. The APAP group also had significantly higher serum neopterin levels than the normal group. Serum neopterin levels correlated with serum AST, ALT activities, and degree of necrosis. This study demonstrates the preclinical utility of neopterin as a biomarker for the animal model of APAP-induced liver injury. Further research studies are required to determine the preclinical opportunities of using neopterin as a marker of APAP-induced liver injury.
新蝶呤由干扰素-γ和其他细胞因子在巨噬细胞/枯否细胞中合成。本研究旨在评估新蝶呤作为乙酰氨基酚(APAP)诱导肝损伤生物标志物的效用。Wistar 大鼠随机分为两组(APAP 和正常),分别通过胃管给予 APAP(1.0 g/kg)和蒸馏水。APAP 组的肝坏死程度高于对照组。APAP 组的血清新蝶呤水平也明显高于正常组。血清新蝶呤水平与血清 AST、ALT 活性和坏死程度相关。本研究证明了新蝶呤作为 APAP 诱导肝损伤动物模型生物标志物的临床前效用。需要进一步的研究来确定新蝶呤作为 APAP 诱导肝损伤标志物的临床前机会。